TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Simcere Pharmaceutical Group Limited ( (HK:2096) ) has provided an announcement.
Simcere Pharmaceutical Group Limited has successfully completed the placing of existing shares and a top-up subscription of new shares, raising approximately HK$1,553.5 million. The proceeds will primarily be used to fund R&D-related expenditures, including advancing clinical research and supporting new drug indications, with a smaller portion allocated for working capital and general corporate purposes. This strategic move is expected to enhance the company’s pipeline progress and market coverage.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a Hong Kong-incorporated company operating in the pharmaceutical industry. The company focuses on the research and development of new drugs, with a market emphasis on advancing clinical research in China and the United States, as well as expanding indications for approved innovative drugs.
Average Trading Volume: 24,304,508
Technical Sentiment Signal: Buy
Current Market Cap: HK$34.97B
See more data about 2096 stock on TipRanks’ Stock Analysis page.